These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22544202)

  • 1. Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.
    Hingankar NK; Thorat SR; Deshpande A; Rajasekaran S; Chandrasekar C; Kumar S; Srikantiah P; Chaturbhuj DN; Datkar SR; Deshmukh PS; Kulkarni SS; Sane S; Reddy DC; Garg R; Jordan MR; Kabra S; Tripathy SP; Paranjape RS
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S348-54. PubMed ID: 22544202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.
    Wadonda-Kabondo N; Hedt BL; van Oosterhout JJ; Moyo K; Limbambala E; Bello G; Chilima B; Schouten E; Harries A; Massaquoi M; Porter C; Weigel R; Hosseinipour M; Aberle-Grasse J; Jordan MR; Kabuluzi S; Bennett DE
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S355-61. PubMed ID: 22544203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.
    Wadonda-Kabondo N; Bennett D; van Oosterhout JJ; Moyo K; Hosseinipour M; Devos J; Zhou Z; Aberle-Grasse J; Warne TR; Mtika C; Chilima B; Banda R; Pasulani O; Porter C; Phiri S; Jahn A; Kamwendo D; Jordan MR; Kabuluzi S; Chimbwandira F; Kagoli M; Matatiyo B; Demby A; Yang C
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S362-8. PubMed ID: 22544204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria.
    Ugbena R; Aberle-Grasse J; Diallo K; Bassey O; Jelpe T; Rottinghaus E; Azeez A; Akpan R; Muhammad M; Shanmugam V; Singh S; Yang C
    Clin Infect Dis; 2012 May; 54 Suppl 4():S375-80. PubMed ID: 22544206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.
    Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique.
    Vaz P; Augusto O; Bila D; Macassa E; Vubil A; Jani IV; Pillon R; Sandstrom P; Sutherland D; Giaquinto C; Jordan MR; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S369-74. PubMed ID: 22544205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.
    Hong SY; Jonas A; DeKlerk M; Shiningavamwe A; Desta T; Badi A; Morris L; Hunt GM; Ledwaba J; Sheehan HB; Lau K; Trotter A; Tang AM; Wanke C; Jordan MR
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):463-71. PubMed ID: 25564107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda.
    Rusine J; Asiimwe-Kateera B; van de Wijgert J; Boer KR; Mukantwali E; Karita E; Gasengayire A; Jurriaans S; de Jong M; Ondoa P
    PLoS One; 2013; 8(8):e64345. PubMed ID: 23950859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China.
    Liao L; Xing H; Su B; Wang Z; Ruan Y; Wang X; Liu Z; Lu Y; Yang S; Zhao Q; Vermund SH; Chen RY; Shao Y
    AIDS; 2013 Jul; 27(11):1815-24. PubMed ID: 23803794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.
    Liu P; You Y; Liao L; Feng Y; Shao Y; Xing H; Lan G; Li J; Ruan Y; Li D
    BMC Infect Dis; 2022 May; 22(1):426. PubMed ID: 35509014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
    Kaleebu P; Kirungi W; Watera C; Asio J; Lyagoba F; Lutalo T; Kapaata AA; Nanyonga F; Parry CM; Magambo B; Nazziwa J; Nannyonjo M; Hughes P; Hladik W; Ruberantwari A; Namuwenge N; Musinguzi J; Downing R; Katongole-Mbidde E;
    PLoS One; 2015; 10(12):e0145536. PubMed ID: 26700639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India.
    Shah B; Walshe L; Saple DG; Mehta SH; Ramnani JP; Kharkar RD; Bollinger RC; Gupta A
    Clin Infect Dis; 2007 May; 44(9):1235-44. PubMed ID: 17407045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique.
    Bila DC; Boullosa LT; Vubil AS; Mabunda NJ; Abreu CM; Ismael N; Jani IV; Tanuri A
    PLoS One; 2015; 10(7):e0130580. PubMed ID: 26151752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.
    Do TN; Nguyen TM; Do MH; Masaya K; Dang TB; Pham TL; Yoshikawa K; Cao TT; Nguyen TT; Bui DD; Nguyen VK; Nguyen TL; Fujita M
    Clin Infect Dis; 2012 May; 54 Suppl 4():S306-12. PubMed ID: 22544193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.
    Bennett DE; Jordan MR; Bertagnolio S; Hong SY; Ravasi G; McMahon JH; Saadani A; Kelley KF
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S280-9. PubMed ID: 22544188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
    Dzangare J; Gonese E; Mugurungi O; Shamu T; Apollo T; Bennett DE; Kelley KF; Jordan MR; Chakanyuka C; Cham F; Banda RM
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S313-6. PubMed ID: 22544194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with HIV virologic failure among patients on HAART for one year at three sentinel surveillance sites in China.
    Wang X; Yang L; Li H; Zuo L; Liang S; Liu W; Dong Y; Yang S; Shang H; Li J; Kang L; Zhong P; Zheng W; Liao L; Xing H; Chen RY; Ruan Y; Shao Y
    Curr HIV Res; 2011 Mar; 9(2):103-11. PubMed ID: 21361864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
    Kan W; Teng T; Liang S; Ma Y; Tang H; Zuohela T; Sun G; He C; Wall KM; Marconi VC; Liao L; Leng X; Liu P; Ruan Y; Xing H; Shao Y
    BMJ Open; 2017 Sep; 7(9):e016012. PubMed ID: 28882911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.